BACKGROUND: Viral illnesses are important factors in both asthma inception and exacerbations, and allergic sensitization in early life further enhances asthma risk through unclear mechanisms. Cellular damage caused by infection or allergen inhalation increases ATP levels in the airways with subsequent purinergic receptor activation. The purinergic receptor P2X(7) can enhance airway leukocyte recruitment to the airways, and P2X(7) knockout mice display a reduced asthma-like phenotype. OBJECTIVE: Based on the P2X(7) knockout mouse, we hypothesized that children with low P2X(7) function would have decreased rates of asthma. METHODS: We used a functional assay to determine P2X(7) pore-producing capacity in whole-blood samples in a birth cohort at high risk for asthma development. The P2X(7) assay was validated with known loss-of-function alleles in human subjects. P2X(7) pore status categorization was used to assess asthma and allergy status in the cohort. RESULTS: Attenuated P2X(7) function was associated with lower asthma rates at ages 6 and 8 years, and the greatest effects were observed in boys. Children with asthma at age 11 years who had low P2X(7) capacity had less severe disease in the previous year. Attenuated P2X(7) function was also associated with sensitization to fewer aeroallergens. CONCLUSION: P2X(7) functional capacity is associated with asthma risk or disease severity, and these relationships appear to be age related.
BACKGROUND: Viral illnesses are important factors in both asthma inception and exacerbations, and allergic sensitization in early life further enhances asthma risk through unclear mechanisms. Cellular damage caused by infection or allergen inhalation increases ATP levels in the airways with subsequent purinergic receptor activation. The purinergic receptor P2X(7) can enhance airway leukocyte recruitment to the airways, and P2X(7) knockout mice display a reduced asthma-like phenotype. OBJECTIVE: Based on the P2X(7) knockout mouse, we hypothesized that children with low P2X(7) function would have decreased rates of asthma. METHODS: We used a functional assay to determine P2X(7) pore-producing capacity in whole-blood samples in a birth cohort at high risk for asthma development. The P2X(7) assay was validated with known loss-of-function alleles in human subjects. P2X(7) pore status categorization was used to assess asthma and allergy status in the cohort. RESULTS: Attenuated P2X(7) function was associated with lower asthma rates at ages 6 and 8 years, and the greatest effects were observed in boys. Children with asthma at age 11 years who had low P2X(7) capacity had less severe disease in the previous year. Attenuated P2X(7) function was also associated with sensitization to fewer aeroallergens. CONCLUSION:P2X(7) functional capacity is associated with asthma risk or disease severity, and these relationships appear to be age related.
Authors: Loren C Denlinger; Giuditta Angelini; Kathleen Schell; Dawn N Green; Arturo G Guadarrama; Usha Prabhu; Douglas B Coursin; Paul J Bertics; Kirk Hogan Journal: J Immunol Date: 2005-04-01 Impact factor: 5.422
Authors: Dagan A Loisel; Zheng Tan; Christopher J Tisler; Michael D Evans; Ronald E Gangnon; Daniel J Jackson; James E Gern; Robert F Lemanske; Carole Ober Journal: J Allergy Clin Immunol Date: 2011-07-27 Impact factor: 10.793
Authors: T Müller; B Robaye; R P Vieira; D Ferrari; M Grimm; T Jakob; S F Martin; F Di Virgilio; J-M Boeynaems; J C Virchow; M Idzko Journal: Allergy Date: 2010-09-29 Impact factor: 13.146
Authors: R Coutinho-Silva; P M Persechini; R D Bisaggio; J L Perfettini; A C Neto; J M Kanellopoulos; I Motta-Ly; A Dautry-Varsat; D M Ojcius Journal: Am J Physiol Date: 1999-05
Authors: N L Korpi-Steiner; D Sheerar; E B Puffer; C Urben; J Boyd; A Guadarrama; K Schell; L C Denlinger Journal: Cytometry B Clin Cytom Date: 2008-09 Impact factor: 3.058
Authors: Loren C Denlinger; David M Manthei; Max A Seibold; Kwangmi Ahn; Eugene Bleecker; Homer A Boushey; William J Calhoun; Mario Castro; Vernon M Chinchili; John V Fahy; Greg A Hawkins; Nicolina Icitovic; Elliot Israel; Nizar N Jarjour; Tonya King; Monica Kraft; Stephen C Lazarus; Erik Lehman; Richard J Martin; Deborah A Meyers; Stephen P Peters; Dagna Sheerar; Lei Shi; E Rand Sutherland; Stanley J Szefler; Michael E Wechsler; Christine A Sorkness; Robert F Lemanske Journal: Am J Respir Crit Care Med Date: 2012-11-09 Impact factor: 21.405
Authors: Laura E Felley; Akshat Sharma; Erin Theisen; James C Romero-Masters; John-Demian Sauer; Jenny E Gumperz Journal: J Immunol Date: 2016-08-17 Impact factor: 5.422